beta-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis
…Severity Index scores (r = 0.53, n = 281, P < .001). Conclusion IL-17A is a primary driver of skin pathology in patients with psoriasis, and serum BD-2 is an easily measurable biomarker of IL-17A–driven skin pathology….
read more